{
    "Trade/Device Name(s)": [
        "VisuLizeTM Factor IX Antigen Kit"
    ],
    "Submitter Information": "Affinity Biologicals Inc.",
    "510(k) Number": "K051054",
    "Predicate Device Reference 510(k) Number(s)": [
        "K854312"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "June 29, 2005",
    "Summary Letter Received Date": "April 26, 2005",
    "Submission Date": "April 25, 2005",
    "Regulation Number(s)": [
        "21CFR864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Factor IX"
    ],
    "Specimen Type(s)": [
        "Human plasma",
        "Factor IX concentrates"
    ],
    "Specimen Container(s)": [
        "3.2% buffered citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "96-microwell ELISA plate"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (ELISA)",
        "Sandwich ELISA",
        "Polyclonal antibody detection"
    ],
    "Methodologies": [
        "Double antibody ELISA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for VisuLizeTM Factor IX Antigen Kit, a sandwich ELISA for quantitative determination of Factor IX in plasma and concentrates",
    "Indications for Use Summary": "Intended for use as an in vitro diagnostic assay for the quantitative determination of Factor IX antigen in human plasma samples and Factor IX concentrates using the double antibody enzyme linked immuno-sorbent assay (ELISA)",
    "fda_folder": "Hematology"
}